SUMMARY Semiquantitative analysis of lactoferrin deficiency in neutrophil polymorphonuclear leucocytes in various haematological and non-haematological disease was carried out by scoring polymorphonuclear leucocytes stained for lactoferrin by the immunoperoxidase method. The staining patterns for lactoferrin were classified into four types (0-III) based on the intensity of reaction, and the sum of the ratings of 100 polymorphonuclear leucocytes was considered as "lactoferrin score" with a possible range of 0-300. As a result, significantly low lactoferrin-scores were frequently observed in acute leukaemias and the acute phase of chronic leukaemias. Of 35 cases with leukaemias, lactoferrin-negative polymorphonuclear leucocytes (type 0) were observed in the following cases: eight cases of acute myelogenous leukaemia (8/14), a case of chronic myelogenous leukaemia (1/10) in blast crisis, one of acute promyelocytic leukaemia (1/1), one of acute monocytic leukaemia (1/2), and a case of chronic myelomonocytic leukaemia (1/2) in a transitional phase to an acute myelomonocytic leukaemia. In two cases of acute myelogenous leukaemia, in which the majority of polymorphonuclear leucocytes were negative for lactoferrin, ultrastructural cytochemical study revealed total lack of specific granules in these polymorphonuclear leucocytes. This suggests that lactoferrin is localised in the specific granules of neutrophils as has been postulated previously by others.
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Lactoferrin is a protective agent against microbial organisms '12 The sum of the ratings of 100 polymorphonuclear leucocytes were defined as "lactoferrin-score" with a possible range from 0 to 300.
ULTRASTRUCTURAL CYTOCHEMISTRY FOR MYELOPEROXIDASE
Buffy coat specimens from two patients with acute myelogenous leukaemia were fixed in 2.0% glutaraldehyde in 0 1 M phosphate buffer (pH 7.4) at 4°C for 30 min. After washing in the buffer, cytochemistry for myeloperoxidase was carriea out according to modified Graham-Karnovsky's method,i5 using 3, 3'-diaminobenzidine (DAB) as a substrate. The samples were then postfixed in 1 % osmium tetroxide for one hour, dehydrated in graded alcohols, and embedded in Epon by routine procedure. The ultrathin sections were mounted on copper grids, stained with uranyl acetate and lead citrate or lead citrate alone, and examined with a JEOL-1OOC electron microscope at an accelerating voltage of 80 kV.
Results

LIGHT MICROSCOPIC IMMUNOCYTOCHEMISTRY FOR LACTOFERRIN
Lactoferrin scores in examined cases are summarised in Fig. 2, and In each patient with haematological disease, most or all polymorphonuclear leucocytes stained positively for lactoferrin with the same pattern as those from healthy volunteers (type III). However, weak or negative reaction was found in some of the polymorphonuclear leucocytes from certain leukaemic patients (type 0-I1). Significantly low lactoferrin-scores were frequently found in AML, and lactoferrin-negative polymorphonuclear leucocytes were encountered in eight patients with AML (8/14) . Except AML, lactoferrin-negative polymorphonuclear leucocytes were found in the following cases: one patient with CML in the stage of blast crisis (1/10 with CML), one patient with APL (1/1), In two cases of AML (case 1 and 2 in Fig. 2) , in which the majority of polymorphonuclear leucocytes were negative for lactoferrin, the ultrastructural morphology and cytochemistry for myeloperoxidase were studied. Clinical and haematological data on these cases are summarised in Table 2 . In case 1, 95 % of the patient's polymorphonuclear leucocytes were negative for lactoferrin (Fig. 3) . These abnormal polymorphonuclear leucocytes contained decreased numbers of cytoplasmic granules, and specific granules were totally absent (Fig. 4) . Primary granules were also decreased in number and showed varying degrees of myeloperoxidase deficiency. Case 2 developed an overt leukaemia after a preleukaemic state of three months duration. Ninetynine percent of the patient's polymorphonuclear leucocytes lacked lactoferrin in the terminal phase. Ultrastructural analysis showed that specific granules were absent in these polymorphonuclear leucocytes (Fig. 5) . Many of the granules present in this patient's polymorphonuclear leucocytes were elongated or spindle-shaped ranging from 045 Am to 1-50 ,tm in larger diameter and contained crystalline structure. These granules were considered as myeloperoxidase-deficient primary granules frequently seen in leukaemic cells'6-20 and occasionally in hereditary anomalous neutrophils2' or normal immature neutrophils.22 The leucocyte alkaline phosphatase (LAP) scores were slightly decreased in case 1 and almost within normal range in case 2 ( Table 2) .
Discussion
The purpose of this study was to estimate the deficiency of lactoferrin in polymorphonuclear leucocytes semiquantitatively by means of a scoring technique and to clarify the ultrastructural abnormalities of lactoferrin-deficient polymorphonuclear leucocytes. In the present study, 35 cases of leukaemias, 21 cases of other haematological diseases and 24 cases of non-haematological diseases were examined with light microscopic immunoperoxidase method, and two cases of acute myelogenous leukaemia were studied with an electron microscope.
Lactoferrin-deficiency in polymorphonuclear leucocytes was frequently observed in acute leukaemias in our study, whereas it was not found in cases of CML except in a case of blast crisis. This result confirmed the earlier report of Mason,'0 who found lactoferrin-deficient polymorphonuclear leucocytes in four cases of acute or subacute myelomonocytic leukaemia, but not in CML. Previous ultrastructural studies of circulating polymorphonuclear leucocytes in leukaemic patients'6 17 revealed abnormalities in granule populations, including absence of specific granules, in cases of AML and CML in blast crisis, but polymorphonuclear leucocytes in CML patients during chronic state were morphologicaily normal except some non-specific minor abnormalities. These data support our findings. On the other hand, Rausch et all" found lactoferrin-deficient polymorphonuclear leucocytes in two cases of acute leukaemias (2/7) and in three cases of CML (3/4) by the immunofluorescence method. Although our data cannot exclude the presence of lactoferrin-deficient polymorphonuclear leucocytes in CML, the discrepancy in cases of CML between two studies may partly derive from the different methods used: the immunoperoxidase and the immunofluorescence method. It is possible that eosinophils, which are negative for lactoferrin, were misinterpreted as lactoferrin-negative neutrophils by the immunofluorescence method. The immunoperoxidase method is more reliable than the immunofluorescence method for the identification of each cell type. However, as stated by Mason,'0 the immunocytochemical method is basically semiquantitative, and a minor reduction of lactoferrin content in neutrophils may not be detectable by this method.
Morphological and cytochemical abnormalities in polymorphonuclear leucocytes have been reported in various disease states, such as congenital neutrophil anomalies'2-14 223-28 as well as acquired disorders including leukaemias.'0" [16] [17] [18] [19] [20] [29] [30] [31] [32] Since lactoferrin-deficient polymorphonuclear leucocytes have been found in non-leukaemic conditions,12-14 deficiency of lactoferrin in neutrophils is not a specific finding for leukaemia. However, this study showed that distinctively low values of lactoferrinscore were found exclusively in cases of leukaemia. Therefore, it seems that low lactoferrin-scores may strongly suggest the presence of a leukaemic process, if not diagnostic. On the other hand, no significant differences of scores were found among acute leukaemias except two cases of AML (case 1 and 2) which showed the extremely low scores. These two cases had, however, no peculiar clinical findings (Table 2 ) as compared to other cases of AML, and scoring for lactoferrin had little diagnostic value for the subclassification of acute leukaemias. In electron microscopic observation, Bainton'6 classified abnormal polymorphonuclear leucocytes in acute leukaemias into three categories: 1) polymorphonuclear leucocytes containing only azurophil granules and lacking specific granules, 2) polymorphonuclear leucocytes containing only specific granules and 3) polymorphonuclear leucocytes containing both types of granules but with the azurophil granules lacking peroxidase activity. Lactoferrin-deficient polymorphonuclear leucocytes in the present study correspond to the first category of Bainton's classification, but they also showed varying degree of peroxidase deficiency. This population of polymorphonuclear leucocytes may be a subtype of the first category: polymorphonuclear leucocytes containing only azurophil (primary) granules deficient in peroxidase.
Concerning the intracellular localisation of leucocyte alkaline phosphatase (LAP), there is no agreement among investigators. Bainton et a!36 observed Miyauchi, Watanabe, Enomoto, Takeuchi leucocyte alkaline phosphatase in specific granules of human myelocyte, whereas other workers found leucocyte alkaline phosphatase in plasma membrane fractions, in atypical granules or vesicles but not in specific granules.632 [37] [38] [39] [40] In our two patients with AML, in which almost all polymorphonuclear leucocytes were negative for lactoferrin and devoid of specific granules, scores for leucocyte alkaline phosphatase were only slightly decreased or almost within normal range. Furthermore, except in a case of blast crisis of CML, lactoferrin deficiency was not found in cases of CML with low scores for leucocyte alkaline phosphatase. These observations suggest that the localisation of these two proteins is different and that leucocyte alkaline phosphatase is at least localised in organelles other than specific granules.
